Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking diazepam and Mounjaro together is not known to be directly dangerous, but the combination deserves careful thought. Mounjaro slows gastric emptying, which can alter how quickly oral medicines are absorbed, and diazepam is a medicine with a narrow therapeutic profile where timing and blood levels matter. Neither drug is automatically ruled out alongside the other, yet this is a conversation your prescriber needs to be part of before you make any change. Both are prescription-only medicines that require clinical assessment, and the right answer depends on your full medical picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A common assumption is that if a drug interaction does not appear on a label or a standard interaction checker, the medicines are safe to combine without any extra thought. With Mounjaro and diazepam, the picture is more nuanced than that. The Mounjaro Summary of Product Characteristics on the eMC acknowledges that tirzepatide's effect on gastric emptying has the potential to influence the rate of absorption of any oral medicine taken alongside it. Diazepam, taken by mouth, falls squarely within that category.
Slowing gastric emptying does not necessarily mean an interaction in the classical sense — where one drug raises or lowers the other's concentration dangerously. What it can mean is that the time it takes diazepam to reach peak absorption shifts. For most people taking a low, occasional dose for anxiety or muscle spasm, that shift may be imperceptible. For someone who takes it regularly, or who is sensitive to its sedative effects, even a modest change in absorption timing could feel noticeable. Fatigue and dizziness are side effects of both Mounjaro and diazepam; if you experience either more than expected, it is worth raising with whoever prescribes your diazepam rather than assuming it will pass.
The honest summary: there is no large clinical dataset specifically studying tirzepatide and diazepam together. What we have is a reasonable mechanistic understanding of why caution is sensible, and that understanding points clearly toward a conversation with your prescriber rather than a self-managed decision.
Mounjaro works by activating GIP and GLP-1 receptors, the only dual-agonist weight-loss medicine licensed in the UK. One consequence of that dual action is a meaningful slowdown in how quickly the stomach empties its contents into the small intestine. That is partly why it reduces appetite and supports weight loss. For food, the effect is broadly helpful. For oral medicines, the picture is more complicated.
Diazepam is absorbed in the upper gastrointestinal tract. If stomach emptying is slowed, the drug spends longer in the stomach before it moves to where absorption actually happens. That could delay the onset of its effects. Equally, once the medicine does pass through, absorption may then proceed normally, so the total amount absorbed over time might not change significantly, even if the curve looks different. The NHS guidance on tirzepatide notes that absorption of co-administered oral medicines can be affected and recommends informing your doctor of all medicines you take. That recommendation exists for a reason.
If you take diazepam occasionally for acute anxiety and you are newly starting Mounjaro, think of it like adjusting any routine when a new variable enters. You might find the usual dose takes slightly longer to settle you. You might notice nothing at all. Either way, your prescriber (not a best guess) should set your expectations.
Both Mounjaro and diazepam carry sedation and dizziness as possible side effects, and that overlap is the practical concern many people overlook. Mounjaro's gastrointestinal side effects (nausea, fatigue, dizziness) are most common in the first weeks of treatment or after a dose increase. Diazepam's sedative effects are well known. If both are on board at the same time, distinguishing which is causing fatigue or lightheadedness is harder, and the additive effect on drowsiness is a real consideration, particularly for driving or operating machinery.
This is not a reason to avoid either medicine. It is a reason to be deliberate. If you are starting Mounjaro while already taking diazepam, tell your Mounjaro prescriber. If you are already on Mounjaro and a GP or specialist recommends diazepam, tell them you are on tirzepatide. Neither should be a barrier to treatment; they are just pieces of information that let the clinician make the right call for you.
Questions about how other medicines interact with tirzepatide come up often, you can read more on our guide to taking other GLP-1 medicines alongside Mounjaro, or explore similar interaction questions, such as Mounjaro and HRT, in more depth. If you are thinking about the broader cost and practicalities of starting treatment, our Mounjaro cost page sets out what to expect from private prescriptions, and if you would like to spread the cost, you can find out how to pay for Mounjaro using PayPal Credit as one of the available options.
The step that matters most is straightforward: tell every prescriber involved in your care what else you are taking. That includes your GP, whoever manages your diazepam prescription, and the prescriber reviewing your Mounjaro treatment. At nume, your consultation is read personally by a GPhC-registered Independent Prescriber (a named clinician, not software) on the same day you submit it, so there is a real opportunity to flag your diazepam use and have it considered properly before treatment begins.
If you are already on Mounjaro and a dose increase is being considered, that is also a relevant moment to revisit any oral medicines you take regularly, including diazepam. The slowing effect on gastric emptying tends to be most pronounced at higher doses, and if you are based in Scotland you can read about accessing treatment through our Mounjaro service in Perth. You can find a fuller picture of the medicine itself on our Mounjaro information page.
If you experience unusual sedation, dizziness that feels out of proportion, or any side effect you are unsure about, do not wait. Reach out to your prescriber. You can also report unexpected side effects to the MHRA via the Yellow Card scheme. And if you have broader questions about how Mounjaro fits your situation, our FAQs and support team are available seven days a week. When you feel ready to discuss treatment properly, you can speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.